These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21528490)

  • 1. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
    J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
    Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
    Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.
    Kimak E; Bylina J; Solski J; Hałabiś M; Baranowicz-Gąszczyk I; Książek A
    Cell Biochem Biophys; 2013 Nov; 67(2):695-702. PubMed ID: 23479335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL).
    Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
    Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gaszczyk I
    J Zhejiang Univ Sci B; 2010 Apr; 11(4):249-57. PubMed ID: 20349521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL.
    Cho KH; Nam HS; Kang DJ; Zee S; Park MH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL and HDL subclass distribution in patients with end-stage renal diseases.
    Alabakovska SB; Todorova BB; Labudovic DD; Tosheska KN
    Clin Biochem; 2002 May; 35(3):211-6. PubMed ID: 12074829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing.
    Hackenhaar FS; Martinez D; Medeiros TM; Klein C; Alabarse PV; Wainstein MV; Gonçalves SC; Benfato MS
    Curr Med Chem; 2012; 19(25):4359-66. PubMed ID: 22934769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients.
    Morena M; Cristol JP; Dantoine T; Carbonneau MA; Descomps B; Canaud B
    Nephrol Dial Transplant; 2000 Mar; 15(3):389-95. PubMed ID: 10692526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.